Page last updated: 2024-10-25

clenbuterol and Myocarditis

clenbuterol has been researched along with Myocarditis in 1 studies

Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.

Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lopes, PM1
Albuquerque, F1
Ferreira, AM1
Trabulo, M1

Other Studies

1 other study available for clenbuterol and Myocarditis

ArticleYear
Clenbuterol-induced myocarditis in a young man desiring to lose weight.
    BMJ case reports, 2022, Mar-14, Volume: 15, Issue:3

    Topics: Clenbuterol; Humans; Magnetic Resonance Imaging; Male; Myocarditis; Myocardium; Weight Loss

2022